The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but ...

Strong cash position of $12.1 million expected to fund operations into the second half of 2026Driving lead program, TPI 287, towards Phase 2 study for treatment of glioblastoma multiforme (GBM) ...

Linda Scelza knew what would happen when she told her son, Ryder, it was “OK to go.” Ryder Scelza took two more breaths and then died in his her arms, she said. He was 21. Ryder Scelza, of Rocky Hill, ...

Gliomas are a type of primary brain tumour originating from glial cells that support and protect nerve cells in the brain and ...

NRG Oncology recently reported the results of the phase II/III NRG-BN007 clinical trial showing that combining ipilimumab and ...

First patient dosed with CUE-102 for recurrent glioblastoma multiforme (rGBM) at Dana-Farber Cancer Institute (DFCI) ...

NRG Oncology recently reported the results of the National Cancer Institute sponsored phase II/III NRG-BN007 clinical trial showing that combining ipilimumab and nivolumab with radiation therapy (RT) ...

Two months ago, Aiken Eakins learned her 63-year-old father had been diagnosed with glioblastoma. She lives in California, ...

Dean Dunphy, 33, was diagnosed with stage 4 brain cancer after experiencing stroke-like symptoms and muscle twitching ...

Glioblastoma is a dangerous brain tumour. It affects many people in the United States. Early signs are often missed. Dr.

The tumor, which occurs when supportive cells in the brain grow and divide uncontrollably, is extremely aggressive and deadly. Most patients survive only 14 to 16 months after diagnosis.